Differentiation-inducing factor-1 induces cyclin D1 degradation through the phosphorylation of Thr286 in squamous cell carcinoma

Experimental Cell Research

Volumn 310, Issue 2, 2005, Pages 426-433

  Mori, Jun ^a,b   Takahashi Yanaga, Fumi ^a   Miwa, Yoshikazu ^a   Watanabe, Yutaka ^c   Hirata, Masato ^b   Morimoto, Sachio ^a   Shirasuna, Kanemitsu ^b   Sasaguri, Toshiyuki ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c EHIME UNIVERSITY   (Japan)

Author keywords

Cell cycle arrest; Cyclin D1; DIF 1; GSK 3 ; SCC

Indexed keywords

ALANINE; CYCLIN D1; DIFFERENTIATION INDUCING FACTOR; DIFFERENTIATION INDUCING FACTOR 1; ENZYME INHIBITOR; GLYCOGEN SYNTHASE KINASE 3BETA; LITHIUM CHLORIDE; MUTANT PROTEIN; RNA; SERINE; THREONINE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CELL NUCLEUS; CONTROLLED STUDY; ENZYME LOCALIZATION; HUMAN; HUMAN CELL; MOLECULAR BIOLOGY; MOUTH CARCINOMA; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DEPHOSPHORYLATION; PROTEIN DEPLETION; PROTEIN PHOSPHORYLATION; RNA INTERFERENCE; SQUAMOUS CELL CARCINOMA; WILD TYPE;

DICTYOSTELIUM; MAMMALIA;

EID: 26844434149     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2005.07.024     Document Type: Article

References (33)

1. C.J. Sherr Cancer cell cycles Science 274 1996 1672 1677
2. R.A. Weinberg The retinoblastoma protein and cell cycle control Cell 81 1995 323 330
3. J.A. Diehl, F. Zindy, and C.J. Sherr Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway Genes. Dev. 11 1997 957 972
4. J.A. Diehl, M. Cheng, M.F. Roussel, and C.J. Sherr Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization Genes Dev. 12 1998 3499 3511
5. D.M. Barnes, and C.E. Gillett Cyclin D1 in breast cancer Breast Cancer Res. Treat. 52 1998 1 15
6. F. Barbieri, P. Lorenzi, N. Ragni, G. Schettini, C. Bruzzo, F. Pedulla, and A. Alama Overexpression of cyclin D1 is associated with poor survival in epithelial ovarian cancer Oncology 66 2004 310 315
7. T. Utsunomiya, Y. Doki, H. Takemoto, H. Shiozaki, M. Yano, M. Sekimoto, S. Tamura, T. Yasuda, Y. Fujiwara, and M. Monden Correlation of beta-catenin and cyclin D1 expression in colon cancers Oncology 61 2001 226 233
8. M. Fu, C. Wang, Z. Li, T. Sakamaki, and R.G. Pestell Cyclin D1: normal and abnormal functions Endocrinology 145 2004 5439 5447
9. T. Callender, A.K. el-Naggar, M.S. Lee, R. Frankenthaler, M.A. Luna, and J.G. Batsakis PRAD-1 (CCND1)/cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma Cancer 74 1994 152 158
10. M. Fujii, R. Ishiguro, T. Yamashita, and M. Tashiro Cyclin D1 amplification correlates with early recurrence of squamous cell carcinoma of the tongue Cancer Lett. 172 2001 187 192
11. H. Mineta, K. Miura, S. Takebayashi, Y. Ueda, K. Misawa, H. Harada, J. Wennerberg, and M. Dictor Cyclin D1 overexpression correlates with poor prognosis in patients with tongue squamous cell carcinoma Oral Oncol. 36 2000 194 198
12. H. Goto, K. Kawano, I. Kobayashi, H. Sakai, and S. Yanagisawa Expression of cyclin D1 and GSK-3β and their predictive value of prognosis in squamous cell carcinomas of the tongue Oral Oncol. 38 2002 549 556
13. N. Uzawa, R. Miyamoto, K. Nakakuki, A. Negishi, Y. Uzawa, and T. Amagasa Analysis of cyclin D1 gene amplification in oral squamous cell carcinoma by FNA-FISH technique Jpn. J. Oral Maxillofac. Surg. 48 2002 245 251
14. H.R. Morris, G.W. Taylor, M.S. Masento, K.A. Jermyn, and R.R. Kay Chemical structure of the morphogen differentiation inducing factor from Dictyostelium discoideum Nature 328 1987 811 814
15. H.R. Morris, M.S. Masento, G.W. Taylor, K.A. Jermyn, and R.R. Kay Structure elucidation of two differentiation inducing factors (DIF-2 and DIF-3) from the cellular slime mould Dictyostelium discoideum Biochem. J. 249 1988 903 906
16. 1 arrest and differentiation of vascular smooth muscle cells Circ. Res. 86 2000 68 75
17. F. Takahashi-Yanaga, Y. Taba, Y. Miwa, Y. Kubohara, Y. Watanabe, M. Hirata, S. Morimoto, and T. Sasaguri Dictyostelium differentiation-inducing factor-3 activates glycogen synthase kinase-3β and degrades cyclin D1 in mammalian cells J. Biol. Chem. 278 2003 9663 9670
18. M. Yoshiya A fibronectin-producing cell line established from a human squamous cell carcinoma of the tongue and its characterization Jpn. J. Oral Maxillofac. Surg. 36 1990 868 880
19. K. Takahashi, H. Kanazawa, Y. Akiyama, S. Tazaki, M. Takahara, T. Muto, H. Tanzawa, and K. Sato Establishment and characterization of a cell line (SAS) from poorly differentiated human squamous cell carcinoma of the tongue J. Jpn. Stomatol. Soc. 38 1989 20 28
20. H. Yoshida, H. Sumichika, S. Hamano, X. He, Y. Minamishima, G. Kimura, and K. Nomoto Induction of apoptosis of T cells by infecting mice with murine cytomegalovirus J. Virol. 69 1995 4769 4775
21. K. Asahi, A. Sakurai, N. Takahashi, Y. Kubohara, K. Okamoto, and Y. Tanaka DIF-1, morphogen of Dictyostelium discoideum, induces the erythroid differentiation in murine and human leukemia cells Biochem. Biophys. Res. Commun. 208 1995 1036 1039
22. Y. Kubohara DIF-1, putative morphogen of D. discoideum, suppresses cell growth and promotes retinoic acid-induced cell differentiation in HL-60 Biochem. Biophys. Res. Commun. 236 1997 418 422
23. Y. Kubohara Effect of differentiation-inducing factors of Dictyostelium discoideum on human leukemia K562 cells: DIF-3 in the most potent anti-leukemic agent Eur. J. Pharmacol. 381 1999 57 62
24. F. Zhang, C.J. Phiel, L. Spece, N. Gurvich, and P.S. Klein Inhibitory phosphorylation of glycogen synthase kinase-3β (GSK-3) in response to lithium J. Biol.Chem. 278 2003 33067 33077
25. M.P. Coghlan, A.A. Culbert, D.A. Cross, S.L. Corcoran, J.W. Yates, N.J. Pearce, O.L. Rausch, G.J. Murphy, P.S. Carter, L. Roxbee Cox, D. Mills, M.J. Brown, D. Haigh, R.W. Ward, D.G. Smith, K.J. Murray, A.D. Reith, and J.C. Holder Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription Chem. Biol. 7 2000 793 803
26. D.M. Ferkey, and D. Kimelman GSK-3: new thoughts on an old enzyme Dev. Biol. 225 2000 471 479
27. L. Kim, and A.R. Kimmel GSK3, a master switch regulating cell-fate specification and tumorigenesis Curr. Opin. Genet. Dev. 10 2000 508 514
28. A.J. Harwood Regulation of GSK-3: a cellular multiprocessor Cell 105 2001 821 824
29. M.J. Spinella, S.J. Freemantle, D. Sekula, J.H. Chang, A.J. Christie, and E. Dmitrovsky Retinoic acid promotes ubiquitination and proteolysis of cyclin D1 during induced tumor cell differentiation J. Biol. Chem. 274 1999 22013 22018
30. D. Germain, A. Russell, A. Thompson, and J. Hendly Ubiquitination of free cyclin D1 is independent of phosphorylation on threonine 286 J. Biol. Chem. 275 2000 12074 12079
31. P. Cohen, and S. Frame The renaissance of GSK-3β Nat. Rev., Mol. Cell. Biol. 2 2001 769 776
32. Y. Zou, D.Z. Ewton, X. Deng, S.E. Mercer, and E. Friedman Mirk/dyrk1B kinase destabilizes cyclin D1 by phosphorylation at threonine 288 J. Biol. Chem. 279 2004 27790 27798
33. K. Shimizu, T. Murata, T. Tagawa, K. Takahashi, R. Ishikawa, Y. Abe, K. Hosaka, and Y. Kubohara Calmodulin-dependent cyclic nucleotide phosphodiesterase (PDE1) is a pharmacological target of Differentiation-inducing factor-1, an antitumor agent isolated from Dictyostelium Cancer Res. 64 2004 2568 2571